vs
亚什兰（ASH）与OMNICELL, INC.（OMCL）财务数据对比。点击上方公司名可切换其他公司
亚什兰的季度营收约是OMNICELL, INC.的1.2倍（$386.0M vs $309.9M），OMNICELL, INC.净利率更高（3.7% vs -3.1%，领先6.8%），OMNICELL, INC.同比增速更快（14.9% vs -4.7%），亚什兰自由现金流更多（$111.0M vs $38.6M），过去两年OMNICELL, INC.的营收复合增速更高（5.8% vs -18.1%）
亚什兰是一家总部位于美国特拉华州威尔明顿的化工企业，1924年始创于肯塔基州亚什兰市，最初以炼油业务起家，1994年迁至现总部。公司拥有多个业务板块，覆盖化工中间体与溶剂、复合材料、工业特种化学品、个人及家居护理、制药、食品饮料以及农业相关领域，2017年之前曾是胜牌润滑油的主要生产商。
Omnicell是总部位于美国加州山景城的跨国医疗科技企业，专注于为医院及各类医疗机构提供药品管理自动化系统，同时面向零售药房推出用药依从性包装与患者互动软件，旗下产品使用Omnicell及EnlivenHealth两大品牌。
ASH vs OMCL — 直观对比
营收规模更大
ASH
是对方的1.2倍
$309.9M
营收增速更快
OMCL
高出19.6%
-4.7%
净利率更高
OMCL
高出6.8%
-3.1%
自由现金流更多
ASH
多$72.4M
$38.6M
两年增速更快
OMCL
近两年复合增速
-18.1%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $386.0M | $309.9M |
| 净利润 | $-12.0M | $11.4M |
| 毛利率 | 27.2% | 45.3% |
| 营业利润率 | -1.6% | 60.1% |
| 净利率 | -3.1% | 3.7% |
| 营收同比 | -4.7% | 14.9% |
| 净利润同比 | 92.7% | — |
| 每股收益（稀释后） | $-0.26 | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASHOMCL
| Q1 26 | — | $309.9M | ||
| Q4 25 | $386.0M | $314.0M | ||
| Q3 25 | $477.0M | $310.6M | ||
| Q2 25 | $463.0M | $290.6M | ||
| Q1 25 | $479.0M | $269.7M | ||
| Q4 24 | $405.0M | $306.9M | ||
| Q3 24 | $521.0M | $282.4M | ||
| Q2 24 | $544.0M | $276.8M |
净利润ASHOMCL
| Q1 26 | — | $11.4M | ||
| Q4 25 | $-12.0M | — | ||
| Q3 25 | $31.0M | $5.5M | ||
| Q2 25 | $-742.0M | $5.6M | ||
| Q1 25 | $31.0M | $-7.0M | ||
| Q4 24 | $-165.0M | — | ||
| Q3 24 | $17.0M | $8.6M | ||
| Q2 24 | $6.0M | $3.7M |
毛利率ASHOMCL
| Q1 26 | — | 45.3% | ||
| Q4 25 | 27.2% | 41.5% | ||
| Q3 25 | 33.3% | 43.3% | ||
| Q2 25 | 28.5% | 43.9% | ||
| Q1 25 | 30.7% | 41.1% | ||
| Q4 24 | 27.4% | 46.2% | ||
| Q3 24 | 33.2% | 43.3% | ||
| Q2 24 | 34.2% | 41.3% |
营业利润率ASHOMCL
| Q1 26 | — | 60.1% | ||
| Q4 25 | -1.6% | 0.1% | ||
| Q3 25 | 12.8% | 2.7% | ||
| Q2 25 | -152.9% | 2.8% | ||
| Q1 25 | 10.6% | -4.3% | ||
| Q4 24 | -44.2% | 4.0% | ||
| Q3 24 | 6.1% | 2.3% | ||
| Q2 24 | -11.2% | 1.2% |
净利率ASHOMCL
| Q1 26 | — | 3.7% | ||
| Q4 25 | -3.1% | — | ||
| Q3 25 | 6.5% | 1.8% | ||
| Q2 25 | -160.3% | 1.9% | ||
| Q1 25 | 6.5% | -2.6% | ||
| Q4 24 | -40.7% | — | ||
| Q3 24 | 3.3% | 3.1% | ||
| Q2 24 | 1.1% | 1.3% |
每股收益（稀释后）ASHOMCL
| Q1 26 | — | $0.25 | ||
| Q4 25 | $-0.26 | $-0.05 | ||
| Q3 25 | $0.83 | $0.12 | ||
| Q2 25 | $-16.21 | $0.12 | ||
| Q1 25 | $0.65 | $-0.15 | ||
| Q4 24 | $-3.50 | $0.34 | ||
| Q3 24 | $0.34 | $0.19 | ||
| Q2 24 | $0.12 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $304.0M | $239.2M |
| 总债务越低越好 | $1.4B | — |
| 股东权益账面价值 | $1.9B | $1.3B |
| 总资产 | $4.5B | $2.0B |
| 负债/权益比越低杠杆越低 | 0.74× | — |
8季度趋势，按日历期对齐
现金及短期投资ASHOMCL
| Q1 26 | — | $239.2M | ||
| Q4 25 | $304.0M | $196.5M | ||
| Q3 25 | $215.0M | $180.1M | ||
| Q2 25 | $207.0M | $399.0M | ||
| Q1 25 | $168.0M | $386.8M | ||
| Q4 24 | $219.0M | $369.2M | ||
| Q3 24 | $300.0M | $570.6M | ||
| Q2 24 | $399.0M | $556.8M |
总债务ASHOMCL
| Q1 26 | — | — | ||
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — |
股东权益ASHOMCL
| Q1 26 | — | $1.3B | ||
| Q4 25 | $1.9B | $1.2B | ||
| Q3 25 | $1.9B | $1.2B | ||
| Q2 25 | $1.9B | $1.3B | ||
| Q1 25 | $2.6B | $1.3B | ||
| Q4 24 | $2.6B | $1.2B | ||
| Q3 24 | $2.9B | $1.2B | ||
| Q2 24 | $3.0B | $1.2B |
总资产ASHOMCL
| Q1 26 | — | $2.0B | ||
| Q4 25 | $4.5B | $2.0B | ||
| Q3 25 | $4.6B | $1.9B | ||
| Q2 25 | $4.6B | $2.1B | ||
| Q1 25 | $5.2B | $2.2B | ||
| Q4 24 | $5.2B | $2.1B | ||
| Q3 24 | $5.6B | $2.3B | ||
| Q2 24 | $5.7B | $2.3B |
负债/权益比ASHOMCL
| Q1 26 | — | — | ||
| Q4 25 | 0.74× | — | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 0.73× | — | ||
| Q1 25 | 0.52× | — | ||
| Q4 24 | 0.51× | — | ||
| Q3 24 | 0.47× | — | ||
| Q2 24 | 0.45× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $125.0M | $54.5M |
| 自由现金流经营现金流 - 资本支出 | $111.0M | $38.6M |
| 自由现金流率自由现金流/营收 | 28.8% | 12.5% |
| 资本支出强度资本支出/营收 | 3.6% | — |
| 现金转化率经营现金流/净利润 | — | 4.80× |
| 过去12个月自由现金流最近4个季度 | $200.0M | $110.8M |
8季度趋势，按日历期对齐
经营现金流ASHOMCL
| Q1 26 | — | $54.5M | ||
| Q4 25 | $125.0M | $30.4M | ||
| Q3 25 | $40.0M | $28.3M | ||
| Q2 25 | $115.0M | $42.8M | ||
| Q1 25 | $9.0M | $25.9M | ||
| Q4 24 | $-30.0M | $56.3M | ||
| Q3 24 | $80.0M | $22.8M | ||
| Q2 24 | $127.0M | $58.7M |
自由现金流ASHOMCL
| Q1 26 | — | $38.6M | ||
| Q4 25 | $111.0M | $22.6M | ||
| Q3 25 | $6.0M | $18.5M | ||
| Q2 25 | $95.0M | $31.0M | ||
| Q1 25 | $-12.0M | $14.8M | ||
| Q4 24 | $-53.0M | $47.2M | ||
| Q3 24 | $42.0M | $13.9M | ||
| Q2 24 | $98.0M | $49.1M |
自由现金流率ASHOMCL
| Q1 26 | — | 12.5% | ||
| Q4 25 | 28.8% | 7.2% | ||
| Q3 25 | 1.3% | 6.0% | ||
| Q2 25 | 20.5% | 10.7% | ||
| Q1 25 | -2.5% | 5.5% | ||
| Q4 24 | -13.1% | 15.4% | ||
| Q3 24 | 8.1% | 4.9% | ||
| Q2 24 | 18.0% | 17.8% |
资本支出强度ASHOMCL
| Q1 26 | — | — | ||
| Q4 25 | 3.6% | 2.5% | ||
| Q3 25 | 7.1% | 3.1% | ||
| Q2 25 | 4.3% | 4.1% | ||
| Q1 25 | 4.4% | 4.1% | ||
| Q4 24 | 5.7% | 3.0% | ||
| Q3 24 | 7.3% | 3.1% | ||
| Q2 24 | 5.3% | 3.5% |
现金转化率ASHOMCL
| Q1 26 | — | 4.80× | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.29× | 5.18× | ||
| Q2 25 | — | 7.58× | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.71× | 2.64× | ||
| Q2 24 | 21.17× | 15.72× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASH
| Personal Care And Household | $123.0M | 32% |
| Other | $120.0M | 31% |
| Specialty Additives | $36.0M | 9% |
| Intermediates And Solvents | $31.0M | 8% |
| Personal Care | $30.0M | 8% |
| Life Sciences | $27.0M | 7% |
| Intermediates | $19.0M | 5% |
OMCL
| Product revenues | $174.8M | 56% |
| Service revenues | $135.1M | 44% |
